"hivウイルス" の関連情報検索結果
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a p...
The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance be...
Women and HIV: Get the Facts on HIV Testing, Prevention, and Treatment - FDA.gov
Women and HIV: Get the Facts on HIV Testing, Prevention, and Treatment FDA.gov
Classes of Antiretrovirals and How They Work - Verywell Health
Classes of Antiretrovirals and How They Work Verywell Health
Luc Montagnier, Nobel-Winning Co-Discoverer of H.I.V., Dies at 89 (Published 2022) - The New York...
Luc Montagnier, Nobel-Winning Co-Discoverer of H.I.V., Dies at 89 (Published 2022) The New York Times
UN health agency ‘strongly recommends’ dolutegravir antiretroviral medication to manage HIV - UN ...
UN health agency ‘strongly recommends’ dolutegravir antiretroviral medication to manage HIV UN News
Booster vaccine doses protect people with HIV against severe COVID-19 - aidsmap
Booster vaccine doses protect people with HIV against severe COVID-19 aidsmap
T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection - ...
T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection Nature.com
Barcelona woman controls HIV for over 15 years without treatment - aidsmap
Barcelona woman controls HIV for over 15 years without treatment aidsmap
Lenacapavir shows continued promise for first-line treatment and highly resistant HIV - aidsmap
Lenacapavir shows continued promise for first-line treatment and highly resistant HIV aidsmap
PD-1 inhibitor budigalimab may delay viral rebound - aidsmap
Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two year...
The amber light: the World Health Organization’s position when an HIV viral load is “suppressed b...
CROI 2022 - aidsmap
CROI 2022 aidsmap
After viral rebound, dolutegravir-based treatment more likely to suppress HIV - aidsmap
After viral rebound, dolutegravir-based treatment more likely to suppress HIV aidsmap
New cases of hepatitis C declining in people with HIV as access to treatment broadens - aidsmap
New cases of hepatitis C declining in people with HIV as access to treatment broadens aidsmap
Lung function declines faster in people living with HIV - aidsmap
Lung function declines faster in people living with HIV aidsmap
One person remains undetectable without HIV drugs almost four years after using an antibody-based...
Biktarvy combination pill may be most effective option for people with HIV and hepatitis B - aidsmap
Biktarvy combination pill may be most effective option for people with HIV and hepatitis B aidsmap
Long-acting injectable treatment highly effective in European cohort studies - aidsmap
Long-acting injectable treatment highly effective in European cohort studies aidsmap
Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovir...
Could antibodies be used for children with HIV instead of pills? - aidsmap
Could antibodies be used for children with HIV instead of pills? aidsmap
Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure - aidsmap
Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure aidsmap
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds aidsmap
Oral lenacapavir can bridge gaps if injections must be missed - aidsmap
Oral lenacapavir can bridge gaps if injections must be missed aidsmap
Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for ...
Resistance testing does not improve viral suppression after first-line failure in South Africa an...
People with HIV express high satisfaction with monthly injectable regimen - aidsmap
People with HIV express high satisfaction with monthly injectable regimen aidsmap
Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...
São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatme...
São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatment aidsmap
German man remains free of HIV nearly 10 years after stem cell transplant - aidsmap
German man remains free of HIV nearly 10 years after stem cell transplant aidsmap
HIV incidence fell by three-quarters in Australian gay men, with strong association with treatmen...
Child with HIV maintains viral suppression for three years off treatment - aidsmap
Child with HIV maintains viral suppression for three years off treatment aidsmap
Reduced-drug treatment becoming common in Paris - aidsmap
Point-of-care viral load tests did not improve viral suppression in Kenyan children - aidsmap
Point-of-care viral load tests did not improve viral suppression in Kenyan children aidsmap
Scientists use gene-edited stem cells to treat HIV — with mixed success - Nature.com
Scientists use gene-edited stem cells to treat HIV — with mixed success Nature.com
Black MSM are 60% less likely to have suppressed HIV than white men in Atlanta - aidsmap
Black MSM are 60% less likely to have suppressed HIV than white men in Atlanta aidsmap
Fostemsavir salvage therapy continues to look good at 96 weeks - aidsmap
Fostemsavir salvage therapy continues to look good at 96 weeks aidsmap
Doravirine/islatravir just as effective as Biktarvy in previously untreated people - aidsmap
Doravirine/islatravir just as effective as Biktarvy in previously untreated people aidsmap
At-home support after HIV diagnosis in Uganda helps people get on ART and stick with it - aidsmap
At-home support after HIV diagnosis in Uganda helps people get on ART and stick with it aidsmap
Hepatitis C virtually eliminated in people with HIV in the Netherlands - aidsmap
Hepatitis C virtually eliminated in people with HIV in the Netherlands aidsmap
Point-of-care viral load tests at delivery improve early preventive treatment for children at ris...
Lower CD4 count and unsuppressed HIV raise the risk for severe COVID-19 - aidsmap
Lower CD4 count and unsuppressed HIV raise the risk for severe COVID-19 aidsmap
Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option - aidsmap
Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option aidsmap
Sixfold increased risk of infant HIV infection and high rates of low birth weight among women wit...
New TB screening methods cut deaths in people with HIV - aidsmap
New TB screening methods cut deaths in people with HIV aidsmap
Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP)...
Trump administration sues Gilead over HIV drugs, putting patent rights on trial - Axios
Trump administration sues Gilead over HIV drugs, putting patent rights on trial Axios
San Francisco shows that long-acting cabotegravir and rilpivirine may be feasible for people with...
African studies show that lowering viral load in the community reduces HIV incidence, but is not ...
More options for second-line treatment in children shown to be safe and effective - aidsmap
More options for second-line treatment in children shown to be safe and effective aidsmap
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir - aidsmap
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir aidsmap
Long-acting injectable treatment maintains viral suppression - aidsmap
Long-acting injectable treatment maintains viral suppression aidsmap
Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment progra...
Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - aidsmap
Reappearance of HIV in "Mississippi Baby" poses questions for early treatment aidsmap
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - aid...
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women aidsmap
Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity - aidsmap
Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity aidsmap
Immune modulator clears pre-cancerous anal lesions - aidsmap
Bictegravir safe and effective in pregnancy - aidsmap
HIV treatment in the womb helped five South African baby boys to stay undetectable off therapy - ...
HIV treatment in the womb helped five South African baby boys to stay undetectable off therapy aidsmap
Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel? - aidsmap
Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel? aidsmap
What Pseudoviruses Bring to the Study of SARS-CoV-2 - The Scientist
What Pseudoviruses Bring to the Study of SARS-CoV-2 The Scientist
Adolescent-centred interventions lead to a 30-percentage-point increase in viral suppression in N...
COVID-19 pandemic has speeded up the implementation of multi-month dispensing - aidsmap
COVID-19 pandemic has speeded up the implementation of multi-month dispensing aidsmap
London patient remains HIV-free after 2.5 years off treatment - aidsmap
London patient remains HIV-free after 2.5 years off treatment aidsmap
Tenofovir (TDF) does not increase risk of kidney disease in people at low risk - aidsmap
Tenofovir (TDF) does not increase risk of kidney disease in people at low risk aidsmap
Options for two-drug simplification expand - aidsmap
Recycling tenofovir better than switch to second-line zidovudine - aidsmap
Recycling tenofovir better than switch to second-line zidovudine aidsmap
Switching to Biktarvy maintains viral suppression in people aged 65 or over - aidsmap
Switching to Biktarvy maintains viral suppression in people aged 65 or over aidsmap
Poor adherence associated with disruptive life events in young people living with HIV - aidsmap
Poor adherence associated with disruptive life events in young people living with HIV aidsmap
Russian fake news is not new: Soviet Aids propaganda cost countless lives - The Guardian
Russian fake news is not new: Soviet Aids propaganda cost countless lives The Guardian
Adherence counselling reverses viral rebound on dolutegravir in 95% of cases - aidsmap
Adherence counselling reverses viral rebound on dolutegravir in 95% of cases aidsmap
Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up - aidsmap
Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up aidsmap
Ibalizumab, active against highly resistant HIV, now approved in US - aidsmap
Ibalizumab, active against highly resistant HIV, now approved in US aidsmap
Antiretroviral drug levels in hair strongly predict viral suppression - aidsmap
Antiretroviral drug levels in hair strongly predict viral suppression aidsmap
Community-based HIV treatment superior to clinic-based care for men in South Africa - aidsmap
Community-based HIV treatment superior to clinic-based care for men in South Africa aidsmap
Viral suppression in Uganda improved by more viral load tests, done faster - aidsmap
Viral suppression in Uganda improved by more viral load tests, done faster aidsmap